[Resistance of the terminal circulatory apparatus of the skin in patients with cutaneous tuberculosis during treatment with conteben and vigantol-forte].
D002199:Capillary Permeability / Q000187:drug effects*; D012867:Skin; D013828:Thioacetazone; D013882:Thiosemicarbazones / Q000627:therapeutic use*; D014376:Tuberculosis; D014382:Tuberculosis, Cutaneous / Q000628:therapy*; D014807:Vitamin D / Q000627:therapeutic use*; D014815:Vitamins
D013882:Thiosemicarbazones; D014815:Vitamins; D014807:Vitamin D; D013828:Thioacetazone
CAPILLARY PERMEABILITY/effect of drugs on; THIOSEMICARBAZONES/therapeutic use; TUBERCULOSIS, CUTANEOUS/therapy; VITAMIN D/therapeutic use
Uber die Resistenz der terminalen Hautstrombahn bei Hauttuberkulösen während der Conteben- und Vigantol-forte-Behandlung.